Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ERN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | GJB3 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
mRNA | LONRF3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | SERPINB8 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | LILRB4 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
mRNA | YME1L1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
mRNA | PTRF | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | FMN1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
mRNA | KHDC1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
mRNA | FYTTD1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |